Carnival Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Carnival (NYSE:CCL)
Benzinga· 2025-12-19 07:37
Carnival Corporation (NYSE:CCL) will release earnings results for its fourth quarter before the opening bell on Friday, Dec. 19.Analysts expect the Miami, Florida-based company to report quarterly earnings at 25 cents per share, up from 14 cents per share in the year-ago period. The consensus estimate for Carnival's quarterly revenue is $6.37 billion, compared to $5.94 billion a year earlier, according to data from Benzinga Pro.The company has beaten analyst estimates for revenue in six straight quarters an ...
A list of major cross-border deals in India's financial sector this year
BusinessLine· 2025-12-19 07:37
India’s financial sector has seen a number of large deals in 2025, including rare transactions involving foreign banks buying significant stakes in Indian lenders.Between January and September 2025, mergers and acquisitions worth $8 billion had concluded across the financial sector, a 127 per cent increase over the same period last year, according to data by Grant Thornton.Here are key facts about the major deals:MUFG - SHRIRAM FINANCEJapan’s MUFG will pick up a 20 per cent stake in Shriram Finance for ...
Gold (XAUUSD) & Silver Price Forecast: Inflation Dip Lifts Metals as Momentum Holds
FX Empire· 2025-12-19 07:34
Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting with competent advisors before making any financial decisions, particularly in relation to investments in cryptocurrencies and CFDs [1]. Group 1 - The website provides general news, personal analysis, and opinions, as well as materials from third parties for educational and research purposes [1]. - It explicitly states that the information should not be interpreted as a recommendation or advice for any financial actions, including investments or purchases [1]. - The content is not tailored to individual financial situations or needs, highlighting the necessity for users to exercise their own discretion [1]. Group 2 - The website includes information about complex financial instruments such as cryptocurrencies and CFDs, which carry a high risk of losing money [1]. - Users are encouraged to conduct their own research and fully understand the workings and risks of any financial instruments before investing [1]. - The website may feature advertisements and promotional content, and FX Empire may receive compensation from third parties related to such content [1].
German Consumer Sentiment Sinks to Near Two-Year Low
WSJ· 2025-12-19 07:33
Group 1 - Economic uncertainty has led to a significant decline in consumer sentiment, reaching a 21-month low [1] - There is an increasing preference among consumers to save rather than spend, indicating a shift in financial behavior [1] - The current economic climate is influencing overall market dynamics and consumer confidence [1]
Billionaire Philippe Laffont Is Selling Nvidia and Buying This Other Magnificent Chip Stock Instead
The Motley Fool· 2025-12-19 07:32
Hedge fund Coatue Management sold 14% of its Nvidia stake during the third quarter.About halfway through every quarter, any institutional investment fund that manages more than $100 million is required to file a Form 13F with the Securities and Exchange Commission (SEC), documenting all the stocks that it bought and sold during the prior quarter.One such firm that I monitor closely is Coatue Management, founded by Philippe Laffont. During the third quarter, Coatue reduced its position in Nvidia (NVDA +1.87% ...
AstraZeneca: Mispriced Growth Following The Oncology Segment Success
Seeking Alpha· 2025-12-19 07:30
Core Insights - The article introduces Aleksandr Molodets as a new contributing analyst focusing on European financials and high-tech industries, including fintech, pharma, and medtech [2] Group 1: Analyst Background - The analyst has a diverse background ranging from investor relations for tech startups to roles in mutual fund strategy and quantitative risk analytics [2] - Holds a Master in Management (Data & Business Analytics) from the Frankfurt School of Finance & Management and is pursuing CFA and FRM certifications [2] - The investment approach is primarily long-term with derivative overlays for hedging and risk control, aiming to combine quantitative models with fundamental research [2] Group 2: Research Focus - The analyst's research focuses on small industry studies and equity research, selecting industries and building sets of comparable firms [2] - Engages with industry professionals to map main drivers and assess growth potential against valuation [2] - The output aims to provide insights on whether a company fits into a solid long-term portfolio [2]
Michelin: Disclosure of trading in own shares - December 19, 2025
Globenewswire· 2025-12-19 07:30
Core Insights - The article discusses the financial status and operational updates of Compagnie Générale des Établissements Michelin, highlighting its capital structure and registration details [1] Financial Overview - The company has a capital of EUR 355,257,268.50, indicating a strong financial foundation [1] Corporate Structure - Michelin is structured as a Partnership Limited by Shares, which may influence its governance and operational strategies [1] Registration Details - The company is registered in Clermont-Ferrand, which is significant for its historical and operational context [1]
Genenta Science Provides Update on CEO Ownership
Globenewswire· 2025-12-19 07:30
Core Viewpoint - Genenta Science provides an update on the ownership position of its CEO and Co-Founder, Pierluigi Paracchi, highlighting his significant investment in the company through open-market purchases of American Depositary Shares (ADSs) [1][2]. Company Ownership - Pierluigi Paracchi has acquired a total of 30,000 ADSs through open-market purchases, with no reported sales [2]. - As of December 19, 2025, Mr. Paracchi owns 2,326,129 ADSs and ordinary shares, representing approximately 10% of Genenta's outstanding share capital [3]. Company Overview - Genenta Science is a clinical-stage immuno-oncology company focused on developing hematopoietic stem cell therapies for solid tumor cancers [4]. - The company's lead product candidate, Temferon™, aims to express immune-therapeutic payloads within the tumor microenvironment, potentially enhancing immune responses [4]. - Genenta has completed a Phase 1 trial for newly diagnosed Glioblastoma Multiforme (GBM) patients, indicating potential for reprogramming the tumor microenvironment and inducing T cell responses [4]. - A Phase 1/2a study for metastatic Renal Cell Carcinoma has been initiated, which will explore combinations with immune checkpoint inhibitors [4]. - Genenta's therapies are designed as one-time monotherapies but may also enhance the efficacy of other approved treatments when used in combination [4].
Michelin: Disclosure of trading in own shares - December 19, 2025
Globenewswire· 2025-12-19 07:30
Core Points - Michelin has disclosed a securities repurchasing program, indicating its strategy to buy back shares to potentially enhance shareholder value [1][2] - The company executed a transaction on December 19, 2025, acquiring a total of 354,772 ordinary shares at an average price of 28.1871 euros per share [1] - The repurchase was conducted over-the-counter, reflecting Michelin's ongoing commitment to managing its capital structure effectively [1] Summary by Category Company Information - Issuer Name: Michelin - Issuer Code: 549300SOSI58J6VIW052 - ISIN Code: FR001400AJ45 - Date of Transaction: December 19, 2025 [1] Transaction Details - Total Volume of Shares Acquired: 354,772 - Average Price per Share: 28.1871 euros - Transaction Platform: Over-the-counter [1] Financial Implications - The share repurchase program is part of Michelin's broader strategy to optimize its capital allocation and return value to shareholders [1][2]
INVL Baltic Sea Growth Fund exits MBL as MidEuropa acquires majority stake
Globenewswire· 2025-12-19 07:30
Core Insights - INVL Baltic Sea Growth Fund has sold its entire stake in MBL Group to MidEuropa, marking the fund's second exit and enabling full repayment to investors [1][2] - MBL is a leading European contract development and manufacturing organization (CDMO) specializing in assisted mobility, rehabilitation, and aged-care equipment, with significant growth in EBITDA since INVL's investment [2][3] - The transaction is seen as a strong endorsement of MBL's business model and long-term potential, with the Lauritsen family reinvesting and Martin Lauritsen continuing as CEO [1][3] Company Overview - MBL, founded in 1988 by the Lauritsen family in Denmark, is the largest European CDMO for medical mobility devices, employing approximately 1,700 professionals across Europe and Asia [2][3] - The company has over 100 registered patents and is recognized for its innovation capabilities, with projected revenue exceeding EUR 120 million by 2025 [2][3] Investment Context - The assisted mobility market is expected to grow due to factors such as population aging and increasing prevalence of chronic conditions, which aligns with MBL's strategic focus [3] - MidEuropa, a leading European private equity investor, aims to support MBL's growth and international expansion, emphasizing the investment's strong fundamentals and long-term growth potential [3][6] Fund Background - INVL Baltic Sea Growth Fund, with a size of EUR 165 million, is one of the leading private equity funds in the Baltics, backed by the European Investment Fund [4] - The fund is managed by INVL Asset Management, which has over 30 years of experience and manages more than EUR 2 billion in various investment strategies [4][5] Transaction Details - The transaction was advised by Jefferies International, with legal, financial, and commercial support from Horten, Deloitte, and L.E.K. respectively [3]